Comparison of different methods of thrombus permeability measurement and impact on recanalization in the INTERRSeCT multinational multicenter prospective cohort study
Language English Country Germany Media print-electronic
Document type Comparative Study, Journal Article, Multicenter Study
Grant support
P300PB_161071
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
PubMed
31713667
DOI
10.1007/s00234-019-02320-y
PII: 10.1007/s00234-019-02320-y
Knihovny.cz E-resources
- Keywords
- Acute ischemic stroke, CTA, NCCT, Recanalization therapies, Thrombus permeability,
- MeSH
- Bayes Theorem MeSH
- Computed Tomography Angiography methods MeSH
- Fibrinolytic Agents therapeutic use MeSH
- Intracranial Thrombosis diagnostic imaging drug therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Tomography, X-Ray Computed methods MeSH
- Prospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Tissue Plasminogen Activator therapeutic use MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Comparative Study MeSH
- Names of Substances
- Fibrinolytic Agents MeSH
- Tissue Plasminogen Activator MeSH
PURPOSE: To compare the association of different measures of intracranial thrombus permeability on non-contrast computerized tomography (NCCT) and computed tomography angiography (CTA) with recanalization with or without intravenous alteplase. METHODS: Patients with anterior circulation occlusion from the INTERRSeCT study were included. Thrombus permeability was measured on non-contrast CT and CTA using the following methods: [1] automated method, mean attenuation increase on co-registered thin (< 2.5 mm) CTA/NCCT; [2] semi-automated method, maximum attenuation increase on non-registered CTA/NCCT (ΔHUmax); [3] manual method, maximum attenuation on CTA (HUmax); and [4] visual method, residual flow grade. Primary outcome was recanalization with intravenous alteplase on the revised AOL scale (2b/3). Regression models were compared using C-statistic, Akaike (AIC), and Bayesian information criterion (BIC). RESULTS: Four hundred eighty patients were included in this analysis. Statistical models using methods 2, 3, and 4 were similar in their ability to discriminate recanalizers from non-recanalizers (C-statistic 0.667, 0.683, and 0.634, respectively); method 3 had the least information loss (AIC = 483.8; BIC = 492.2). A HUmax ≥ 89 measured with method 3 provided optimal sensitivity and specificity in discriminating recanalizers from non-recanalizers [recanalization 55.4% (95%CI 46.2-64.6) when HUmax > 89 vs. 16.8% (95%CI 13.0-20.6) when HUmax ≤ 89]. In sensitivity analyses restricted to patients with co-registered CTA/NCCT (n = 88), methods 1-4 predicted recanalization similarly (C-statistic 0.641, 0.688, 0.640, 0.648, respectively) with Method 2 having the least information loss (AIC 104.8, BIC 109.8). CONCLUSION: Simple methods that measure thrombus permeability are as reliable as complex image processing methods in discriminating recanalizers from non-recanalizers.
Bezmialem Vakif Univesitesi Noroloji Istanbul Turkey
Centre Hospitalier de l'Université de Montréal University of Montréal Montreal Québec Canada
Charles LeMoyne Hospital University of Sherbrooke Greenfield Park Canada
Department of Neurology Chosun University School of Medicine Gwangju Republic of Korea
Dr Josep Trueta University Hospital Girona Spain
Gosford Hospital Gosford Australia
King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia
Miller School of Medicine University of Miami Miami Florida USA
Queen's University Kingston Ontario Canada
Universidad de Valladolid Valladolid Spain
University of British Columbia Vancouver British Columbia Canada
See more in PubMed
AJNR Am J Neuroradiol. 2014 Dec;35(12):2265-72 PubMed
Stroke. 2016 Aug;47(8):1972-3 PubMed
AJNR Am J Neuroradiol. 2018 Oct;39(10):1854-1859 PubMed
Stroke. 2015 Apr;46(4):968-75 PubMed
Stroke. 2016 Mar;47(3):732-41 PubMed
Stroke. 2016 Aug;47(8):2058-65 PubMed
JAMA. 2018 Sep 11;320(10):1017-1026 PubMed